论文部分内容阅读
AIM To study whether adalimumab (ADA) wasassociated with improvement in growth, bone mineral density (BMD) and bone metabolism.METHODS: In children with Crohn's disease (CD)there is a high prevalence of growth failure andreduced BMD. Treatment with inflix